Related Experiment Video
Updated: May 20, 2025
Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Differences in risk factors for mortality between T2N1M0 and T3N0M0 lobular breast cancer patients: a comparative
Longjie Xia1, Chunxin Qin2, Wei Chen3
1College of Life Science and Technology, Guangxi University, Nanning, China.
Objective:
This study aimed to explore the differences in risk factors for mortality between T2N1M0 and T3N0M0 lobular breast cancer, and investigate the factors associated with non-lobular breast cancer mortality.
Methods:
Data from 2,693 T2N1M0 and 1,384 T3N0M0 lobular breast cancer patients from the SEER database (2008-2018) were analyzed. The lobular breast cancer-specific and non-lobular breast cancer mortality were compared using the Kaplan-Meier curve and Log-rank test. The Cox proportional hazards regression analysis was used to determine the risk factors associated with non-lobular breast cancer mortality.
Results:
The total survival time showed a significant difference between the T2N1M0 and T3N0M0 groups (p = 0.0011). Statistically significant difference were found in lung-related disease mortality (p = 0.0023), with the survival rate of T2N1M0 higher than that of T3N0M0. Age, surgery, radiotherapy, and chemotherapy were independent factors associated with mortality in lung-related disease patients with both subtypes, and compared with T2N1M0, radiotherapy in T3N0M0 increased the risk of lung-related disease mortality (HR = 2.076, 95% CI: 1.4318-3.011).
Conclusion:
The T3N0M0 group had a higher mortality rate from lung-related diseases compared to the T2N1M0 group, and radiotherapy may increase the risk of lung-related disease death in T3N0M0 patients. These findings provide valuable information for treatment strategies for T2N1M0 and T3N0M0 subtypes of patients and assist physicians and patients make better treatment choices.
